Cardiff Oncology, Inc. (CRDF) SEC Filings — 2025
9 SEC filings for Cardiff Oncology, Inc. (CRDF) in 2025.
Filings
- Cardiff Oncology's Q3 Net Loss Narrows, Cash Reserves Dwindle — 10-Q · Nov 6, 2025
- Cardiff Oncology's Q2 Net Loss Widens to $14.1M Amid R&D Spend — 10-Q · Jul 29, 2025
- Cardiff Oncology Files 8-K on Security Holder Vote — 8-K · Jun 26, 2025
- Cardiff Oncology Appoints New CMO, Directors — 8-K · Jun 17, 2025
- Cardiff Oncology Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Cardiff Oncology Files Definitive Proxy Statement — DEFA14A · Apr 30, 2025
- Cardiff Oncology DEF 14A: Executive Compensation Details — DEF 14A · Apr 29, 2025
- Cardiff Oncology Files 2024 10-K — 10-K · Feb 27, 2025
- Cardiff Oncology Files 8-K for Bylaws and Financials — 8-K · Jan 6, 2025